Back to results
US 2001/0025033 A1Published application
Enzyme inactivators
AssigneeSmithKline Beecham Corporation
InventorsThomas Spector, David J.T. Porter, Saad George Rahim
Life of this patent
Estimating the term…
Abstract
Use of uracil reductase inactivators such as 5-substituted uracil derivatives for example 5-ethynyluracil to reduce the toxicity of the anti-HIV nucleoside analogue zidovudine.
Claims5
A pharmaceutical composition comprising uracil substituted in the 5-position by C2-4 alkynyl together with at least one pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.